Genelux GNLX
NASDAQ GNLX
$2.02 -0.05 (-2.42%)
As of: Oct 22, 2026 · 2:34 PM EDT

Genelux (GNLX) Non Operating Interest Expenses (2022 - 2023)

Updated

Genelux (GNLX) recorded Non Operating Interest Expenses of -$131,000 in Q4 2023.

Analysis

Genelux (GNLX) Non Operating Interest Expenses (2022 - 2023) Analysis & Trends

For FY2023, Genelux reported Non Operating Interest Expenses of $36,000.

  • Per Business Quant, the preceding three quarters came in at $131,000 (Q3 2023), -$107,000 (Q2 2023) and $143,000 (Q1 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn -
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn 217.00 Mn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn -
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn -
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn 435.00 Mn
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn -
10 Genelux 88.96 Mn 27.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 -131,000.00
Sep 30, 2023 131,000.00
Jun 30, 2023 -107,000.00
Mar 31, 2023 143,000.00
Mar 31, 2022 288,000.00
API Access

Genelux Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=GNLX&period=max&api_key=YOUR_API_KEY